Skip to content

In the BioHarmony Drug Report Database

Interferon gamma-1b

Actimmune, Betaferon, Extavia (interferon gamma-1b) is a protein pharmaceutical. Interferon gamma-1b was first approved as Actimmune on 1995-11-30. It is used to treat bacterial infections, brain neoplasms, chronic hepatitis c, colorectal neoplasms, and cryoglobulinemia amongst others in the USA. It has been approved in Europe to treat multiple sclerosis.
Trade Name Betaferon, Extavia
Common Name Interferon gamma-1b
Indication bacterial infections, brain neoplasms, chronic hepatitis c, colorectal neoplasms, cryoglobulinemia, essential thrombocythemia, hairy cell leukemia, hemangioma, hepatitis d, hepatocellular carcinoma, hypereosinophilic syndrome, ileal neoplasms, kaposi sarcoma, macular degeneration, melanoma, multiple myeloma, multiple sclerosis, mycosis fungoides, osteopetrosis, renal cell carcinoma, sezary syndrome, skin neoplasms, skin ulcer, thrombocytopenia, warts
Drug Class
Interferon gamma-1b
Get full access now